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Technology innovation, workforce development, and regulatory advancement have been a hallmark of the 
industry for the past several decades. As the industry continues to expand, mature and evolve, there are new 
opportunities for shared risk in technology innovation, for partnerships to facilitate training, and for new 
approaches to engage with health authorities. It can be argued that collaborative efforts in this space, done 
appropriately, can 1) reduce the burden and investment that would otherwise be required by individual 
organizations to advance their technology needs and address issues with speed, quality, and cost; 2) refocus 
academic faculty on the training of students who are better prepared for industry careers; and 3) help faculty 
better understand the current technology needs of existing industry. Collaborate public-private partnerships offer 
one way to bring stakeholders together as well as pay for relevant activities. This presentation is intended to 
catalyze a discussion regarding the opportunities and challenges associated with collaborative technology 
development and will include a discussion about the ways that stakeholders may collaborate to create 
opportunities for the biopharmaceutical industry, government, and academic partners. 
 
 
 
